ES538231A0 - Procedimiento para la preparacion de derivado de esfingosina. - Google Patents

Procedimiento para la preparacion de derivado de esfingosina.

Info

Publication number
ES538231A0
ES538231A0 ES538231A ES538231A ES538231A0 ES 538231 A0 ES538231 A0 ES 538231A0 ES 538231 A ES538231 A ES 538231A ES 538231 A ES538231 A ES 538231A ES 538231 A0 ES538231 A0 ES 538231A0
Authority
ES
Spain
Prior art keywords
procedure
preparation
sphingosin
derivative
sphingosin derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES538231A
Other languages
English (en)
Other versions
ES8604986A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ICN Switzerland AG
Original Assignee
Solco Basel AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH6493/83A external-priority patent/CH679209A5/de
Application filed by Solco Basel AG filed Critical Solco Basel AG
Publication of ES538231A0 publication Critical patent/ES538231A0/es
Publication of ES8604986A1 publication Critical patent/ES8604986A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES538231A 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina. Expired ES8604986A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH6493/83A CH679209A5 (en) 1983-12-05 1983-12-05 New neutral glyco-sphingolipid derivs.
CH467184 1984-09-28

Publications (2)

Publication Number Publication Date
ES538231A0 true ES538231A0 (es) 1986-03-16
ES8604986A1 ES8604986A1 (es) 1986-03-16

Family

ID=25696036

Family Applications (2)

Application Number Title Priority Date Filing Date
ES538231A Expired ES8604986A1 (es) 1983-12-05 1984-12-04 Procedimiento para la preparacion de derivado de esfingosina.
ES548901A Expired ES8606373A1 (es) 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES548901A Expired ES8606373A1 (es) 1983-12-05 1985-11-02 Procedimiento para la preparacion de derivados de esfingosina

Country Status (11)

Country Link
US (1) US4952683A (es)
EP (1) EP0146810A3 (es)
AU (1) AU570087B2 (es)
CA (1) CA1259610A (es)
DK (1) DK573384A (es)
ES (2) ES8604986A1 (es)
FI (1) FI844775L (es)
HU (1) HU195516B (es)
NO (1) NO844815L (es)
PL (1) PL143901B1 (es)
YU (2) YU202784A (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199116B (it) * 1984-07-03 1988-12-30 Fidia Farmaceutici Derivati di gangliosidi
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
US4769362A (en) * 1985-10-01 1988-09-06 Trustees Of Boston University Increased vascular perfusion following administration of lipids
JPH07116209B2 (ja) * 1986-04-11 1995-12-13 メクト株式会社 シアロシルセラミド類及びその製造方法
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
EP0299201A3 (de) * 1987-06-12 1990-08-22 Wilhelm Dr. Hoerrmann Fett-Aminoalkohol enthaltendes Arzneimittel
US5010059A (en) * 1987-06-26 1991-04-23 Solco Basel Ag Pharmaceutical products and lactosyl compounds
US4957741A (en) * 1988-08-02 1990-09-18 Angio-Medical Corp. Method for the treatment of gastric ulcer
US5066496A (en) * 1988-08-03 1991-11-19 Angio-Medical Corporation Composition and method for treatment of gastric and duodenal ulcers and mucosal erosions
IT1235162B (it) * 1988-12-02 1992-06-22 Fidia Farmaceutici Derivati di lisosfingolipidi
DE3916072A1 (de) * 1989-05-17 1990-11-22 Thera Ges Fuer Patente Ceramidderivate und ihre verwendung als inhibitoren der sphingolipidsynthese
DE4102817A1 (de) * 1991-01-31 1992-08-06 Merck Patent Gmbh Verfahren zur stereoselektiven herstellung von (beta)-fucopyranosyl-phosphaten und sehr reiner gdp-fucose
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
TW261533B (es) * 1992-07-16 1995-11-01 Kirin Brewery
ATE191916T1 (de) * 1992-10-22 2000-05-15 Kirin Brewery Neues sphingolglycolipid und verwendung davon
JP4020958B2 (ja) * 1993-04-15 2007-12-12 キリンファーマ株式会社 新規スフィンゴ糖脂質およびその使用
EP0716589A4 (en) * 1993-07-23 1997-06-11 Morris Herstein COSMETIC COMPOSITION STIMULATING THE RENEWAL OF THE SKIN WITH A PROLONGED IRRITATION ELIMINATION EFFECT
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
CA2142153A1 (en) * 1994-03-04 1995-09-05 Jacques Banville Sulfated .beta.-glycolipid derivatives as cell adhesion inhibitors
US5686426A (en) * 1994-11-17 1997-11-11 Bristol-Myers Squibb Company Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
WO1996023523A1 (en) * 1995-02-03 1996-08-08 Korea Institute Of Science And Technology Novel hemostatic composition
EP0869185B9 (en) * 1997-03-03 2004-08-11 Sumitomo Chemical Company, Limited Production of optically active sphingoid compound
US6503885B1 (en) 1998-09-21 2003-01-07 Otsuka Pharmaceutical Co., Ltd. Carboxymethylgalactose derivatives
US20040180852A1 (en) * 2003-03-10 2004-09-16 Cara-Lynne Schengrund Use of multivalent glycodendrimers to inhibit the activity of human immunodeficiency virus
DE102004025000A1 (de) * 2004-05-21 2005-12-08 Bayer Technology Services Gmbh Verfahren zur Herstellung von chemischen und pharmazeutischen Produkten mit integrierter Mehrsäulen-Chromatographie
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
WO2007112322A2 (en) * 2006-03-28 2007-10-04 Allergan, Inc. Indole compounds having sphingosine-1-phosphate (s1p) receptor agonist and/or antagonist biological activity
US7794722B2 (en) * 2006-06-30 2010-09-14 The Scripps Research Institute Adjuvants and methods of use
US8524917B2 (en) * 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
JP2010515750A (ja) 2007-01-11 2010-05-13 アラーガン インコーポレイテッド スフィンゴシン−１−ホスフェート（ｓ１ｐ）受容体アンタゴニスト生物活性を有する６−置換インドール−３−カルボン酸アミド化合物
CA2700539A1 (en) * 2007-09-24 2009-04-02 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
US8143291B2 (en) 2008-05-09 2012-03-27 Allergan, Inc. Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (S1P) receptor biological activity
CN102119140B (zh) * 2008-08-12 2014-09-03 阿勒根公司 1-磷酸鞘氨醇（s1p）受体拮抗剂及其使用方法
WO2011008475A1 (en) 2009-06-30 2011-01-20 Allergan, Inc. Optionally substituted 2-(arylmethyl, aryloxy or arylthio) -n- pyridin-2 -yl-aryl acetamide or 2, 2-bis (aryl) -n-pyridin-2-yl acetamide compounds as medicaments for the treatment of eye diseases
US8168795B2 (en) * 2009-08-11 2012-05-01 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
WO2011028927A1 (en) 2009-09-04 2011-03-10 Allergan, Inc. Selective sphingosine-1-phosphate receptor antagonists
CA2775587A1 (en) 2009-09-29 2011-04-07 Allergan, Inc. Condensed ring pyridine compounds as subtype-selective modulators of sphingosine-1-phosphate-2 (s1p2) receptors
NZ599966A (en) * 2009-11-24 2014-09-26 Allergan Inc Novel compounds as receptor modulators with therapeutic utility
US8741875B2 (en) 2009-11-24 2014-06-03 Allergan, Inc. Compounds as receptor modulators with therapeutic utility
CN103328492A (zh) 2010-11-22 2013-09-25 阿勒根公司 作为受体调节剂具有疗效的新型化合物
US9708354B2 (en) 2013-03-15 2017-07-18 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
US20140316154A1 (en) 2013-03-15 2014-10-23 Cerenis Therapeutics Holding Sa Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
EP4281435A1 (en) 2021-01-25 2023-11-29 Carbocode S.A. Method for the production of d-erythro-sphingosine and analogs thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1495548A (en) * 1974-04-16 1977-12-21 Tate & Lyle Ltd Sugar derivative containing vinyl groups and copolymers thereof
US4362720A (en) * 1977-04-14 1982-12-07 Chembiomed Ltd. Synthesis of 2-amino-2-deoxyglycoses and 2-amino-2-deoxyglycosides from glycals

Also Published As

Publication number Publication date
HUT36833A (en) 1985-10-28
DK573384A (da) 1985-06-06
EP0146810A3 (de) 1987-05-13
PL143901B1 (en) 1988-03-31
YU202784A (en) 1987-02-28
FI844775A0 (fi) 1984-12-04
YU189686A (en) 1987-12-31
ES8604986A1 (es) 1986-03-16
AU3628684A (en) 1985-06-13
PL250710A1 (en) 1985-07-16
EP0146810A2 (de) 1985-07-03
HU195516B (en) 1988-05-30
ES548901A0 (es) 1986-04-16
NO844815L (no) 1985-06-06
FI844775L (fi) 1985-06-06
AU570087B2 (en) 1988-03-03
US4952683A (en) 1990-08-28
ES8606373A1 (es) 1986-04-16
DK573384D0 (da) 1984-12-03
CA1259610A (en) 1989-09-19

Similar Documents

Publication Publication Date Title
ES538231A0 (es) Procedimiento para la preparacion de derivado de esfingosina.
ES533260A0 (es) Procedimiento para la preparacion de 13a-alquilgonanos
ES514795A0 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina.
ES538621A0 (es) Procedimiento para la preparacion de fenolsulfonftaleinil-b-d-galactosidos
ES534607A0 (es) Un procedimiento para la preparacion de un derivado de poliol-eter.
ES537393A0 (es) Procedimiento para la preparacion de derivados succilinados de la heparina n-desulfatada.
ES514887A0 (es) Procedimiento para la preparacion de derivados de la piridazina.
ES532572A0 (es) Procedimiento para la preparacion de n-piridilindoles
ES538464A0 (es) Procedimiento para la preparacion de derivados de acilamida.
ES531814A0 (es) Procedimiento para la preparacion de nuevos derivados de acidos fenilalcanoicos.
ES532957A0 (es) Procedimiento para la preparacion de sulfonilureas substituidas
ES546506A0 (es) Procedimiento para la preparacion de nuevos derivados de 3-fenil-4-cianopirrol.
AR240460A1 (es) Procedimeitno para la preparacion de derivados de antraciclina.
MX156242A (es) Procedimiento para la preparacion de eter-sulfonatos
ES520537A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
ES517288A0 (es) Procedimiento para la preparacion de derivados de azolil-penteno.
ES528114A0 (es) Procedimiento para la preparacion de hexanorbrassinolid-22-eteres
ES523990A0 (es) Procedimiento para la preparacion de furobenzoisoxazoles.
ES543366A0 (es) Procedimiento para la preparacion de derivados de feniletilamina.
MX159632A (es) Procedimiento para la preparacion de derivados de pirimidina 2,4,6,triona
MX159538A (es) Procedimiento para la preparacion de 3-acil-2-nitrometilen-tetrahidro-2h-1,3-tiazina
ES520986A0 (es) Procedimiento para la preparacion de derivados de 2-piridona.
ES517830A0 (es) Procedimiento para la preparacion de derivados ergoticos.
ES531024A0 (es) Procedimiento para la preparacion de aminonitrilos
ES522859A0 (es) Procedimiento para la obtencion de derivados de trifluormetilfenoxi-fenilo.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970303